Kung; Mei-Ping

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kung; Mei-Ping.The latest application filed is for "styrylpyridine derivatives and their use for binding and imaging amyloid plaques".

Company Profile

0.23.20

Kung; Mei-Ping - Wynnewood PA
Kung; Mei-Ping - Winnewood PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Styrylpyridine derivatives and their use for binding and imaging amyloid plaques Grant 8,840,866 - Kung , et al. September 23, 2	2014-09-23
Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents Grant 8,562,949 - Kung , et al. October 22, 2	2013-10-22
Styrylpyridine derivatives and their use for binding and imaging amyloid plaques Grant 8,506,929 - Kung , et al. August 13, 2	2013-08-13
Amyloid plaque aggregation inhibitors and diagnostic imaging agents Grant RE44,354 - Kung , et al. July 9, 2	2013-07-09
Amyloid plaque aggregation inhibitors and diagnostic imaging agents Grant RE44,338 - Kung , et al. July 2, 2	2013-07-02
Stilbene derivatives and their use for binding and imaging amyloid plaques Grant 8,465,726 - Kung , et al. June 18, 2	2013-06-18
Styrylpyridine Derivatives And Their Use For Binding And Imaging Amyloid Plaques App 20130129624 - Kung; Hank F. ; et al.	2013-05-23
Diphenyl-heteroaryl Derivatives And Their Use For Binding And Imaging Amyloid Plaques App 20110158907 - Kung; Hank F. ; et al.	2011-06-30
Stilbene derivatives and their use for binding and imaging amyloid plaques Grant 7,858,072 - Kung , et al. December 28, 2	2010-12-28
Stilbene Derivatives And Their Use For Binding And Imaging Amyloid Plaques App 20100266500 - Kung; Hank F. ; et al.	2010-10-21
Stilbene derivatives and their use for binding and imaging amyloid plaques Grant 7,807,135 - Kung , et al. October 5, 2	2010-10-05
Phen-naphthalene And Phen-quinoline Derivatives And Their Use For Binding And Imaging Amyloid Plaques App 20100215579 - Kung; Hank F. ; et al.	2010-08-26
Stilbene derivatives and their use for binding and imaging amyloid plaques Grant 7,759,502 - Kung , et al. July 20, 2	2010-07-20
Styrylpyridine derivatives and their use for binding and imaging amyloid plaques Grant 7,687,052 - Kung , et al. March 30, 2	2010-03-30
Acetylene derivatives and their use for binding and imaging amyloid plaques Grant 7,678,819 - Kung , et al. March 16, 2	2010-03-16
Styrylpyridine Derivatives and Their Use for Binding and Imaging Amyloid Plaques App 20090123369 - Kung; Hank F. ; et al.	2009-05-14
Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques App 20080253967 - Kung; Hank F. ; et al.	2008-10-16
Amyloid plaque aggregation inhibitors and diagnostic imaging agents Grant 7,425,318 - Kung , et al. September 16, 2	2008-09-16
Acetylene Derivatives And Their Use For Binding And Imaging Amyloid Plaques App 20080166299 - Kung; Hank F. ; et al.	2008-07-10
Stilbene Derivatives And Their Use For Binding And Imaging Amyloid Plaques App 20080108840 - Kung; Hank F. ; et al.	2008-05-08
Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents App 20080050312 - Kung; Hank F. ; et al.	2008-02-28
Stryrylpyridine derivates and theur use for binding and imaging amylod plaques App 20080038195 - Kung; Hank F. ; et al.	2008-02-14
Stilbene derivatives and their use for binding and imaging amyloid plaques Grant 7,297,820 - Kung , et al. November 20, 2	2007-11-20
Compounds and methods useful for rescuing cells from beta-amyloid toxicity and treatment of Alzheimer's disease App 20070254889 - Jin; Lee-Way ; et al.	2007-11-01
Stilbene derivatives and their use for binding and imaging amyloid plaques Grant 7,250,525 - Kung , et al. July 31, 2	2007-07-31
Stilbene derivatives and their use for binding and imaging amyoid plaques App 20060269473 - Kung; Hank F. ; et al.	2006-11-30
Stilbene derivatives and their use for binding and imaging amyloid plaques App 20060269474 - Kung; Hank F. ; et al.	2006-11-30
Amyloid plaque aggregation inhibitors and diagnostic imaging agents App 20060051293 - Kung; Hank F. ; et al.	2006-03-09
Stilbene derivatives and their use for binding and imaging amyloid plaques App 20060002853 - Kung; Hank F. ; et al.	2006-01-05
Biphenyls and fluorenes as imaging agents in alzheimer's disease App 20050271584 - Kung, Hank F. ; et al.	2005-12-08
Amyloid plaque aggregation inhibitors and diagnostic imaging agents Grant 6,946,116 - Kung , et al. September 20, 2	2005-09-20
Amyloid plaque aggregation inhibitors and diagnostic imaging agents App 20040131545 - Kung, Hank F. ; et al.	2004-07-08
Amyloid plaque aggregation inhibitors and diagnostic imaging agents Grant 6,696,039 - Kung , et al. February 24, 2	2004-02-24
Stilbene derivatives and their use for binding and imaging amyloid plaques App 20030149250 - Kung, Hank F. ; et al.	2003-08-07
Amyloid plaque aggregation inhibitors and diagnostic imaging agents App 20030059369 - Kung, Hank F ; et al.	2003-03-27
Dopamine and serotonin transporter ligands and imaging agents Grant 6,241,963 - Kung , et al. June 5, 2	2001-06-05
Dopamine and serotonin transporter ligands and imaging agents Grant 5,980,860 - Kung , et al. November 9, 1	1999-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.